Are you Dr. Ho?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 4 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4501 X St
Suite 3016
Sacramento, CA 95817Phone+1 916-734-3772Fax+1 916-734-7946- Is this information wrong?
Summary
- Dr. Cheryl Ho, MD is an oncologist in Sacramento, California.
Clinical Trials
- Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC Start of enrollment: 2019 Mar 19
- Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC Start of enrollment: 2020 May 26
Publications & Presentations
PubMed
- Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships.Alex A. Adjei, Sai-Hong Ignatius Ou, Cheryl Ho, Jean-Louis Pujol, Sumithra J. Mandrekar, Emily Stone, Andrea Bezjak, D. Ross Camidge> ;Journal of Thoracic Oncology. 2021 May 1
- 2 citationsDual Inhibition: Combining Epidermal Growth Factor–Targeted Therapies in Non–Small-Cell Lung CancerCheryl Ho, Angela M. Davies, Philip C. Mack, David R. Gandara> ;Clinical Lung Cancer. 2007 Jul 1
- 3 citationsPhase II Trial of Pemetrexed in Patients with Selected Stage IIIB/IV Bronchioloalveolar CarcinomaCheryl Ho, Helen J. Ross, Angela M. Davies> ;Clinical Lung Cancer. 2006 Nov 1
- Join now to see all
Press Mentions
UBC, BC Cancer Researchers Develop AI Model to Predict Cancer Survival RatesMarch 27th, 2023- How the Pandemic Has Hurt the Health of People Experiencing HomelessnessSeptember 29th, 2021
- Roche Canada Announces Collaboration to Improve Access to Personalized Healthcare with Real World EvidenceMay 28th, 2021
- Join now to see all
